Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP576115.RAChCy2fRh8bVqzfXuKuuZh3LD5AFkt4LRfXgFbGcICJo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP576115.RAChCy2fRh8bVqzfXuKuuZh3LD5AFkt4LRfXgFbGcICJo130_assertion type Assertion NP576115.RAChCy2fRh8bVqzfXuKuuZh3LD5AFkt4LRfXgFbGcICJo130_head.
- NP576115.RAChCy2fRh8bVqzfXuKuuZh3LD5AFkt4LRfXgFbGcICJo130_assertion description "[The odds ratios were 8.9 (95% CI 5.7 - 13.7) for hyperhomocysteinemia, 3.9 (95% CI 2.3 - 6.7) for anticardiolipin antibodies, 1.2 (95% CI 0.9 - 1.6) for MTHFR, 1.5 (95% CI 1.0 - 2.2) for factor V Leiden mutation and 1.6 (95% CI 0.8 - 3.2) for prothrombin gene mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP576115.RAChCy2fRh8bVqzfXuKuuZh3LD5AFkt4LRfXgFbGcICJo130_provenance.
- NP576115.RAChCy2fRh8bVqzfXuKuuZh3LD5AFkt4LRfXgFbGcICJo130_assertion evidence source_evidence_literature NP576115.RAChCy2fRh8bVqzfXuKuuZh3LD5AFkt4LRfXgFbGcICJo130_provenance.
- NP576115.RAChCy2fRh8bVqzfXuKuuZh3LD5AFkt4LRfXgFbGcICJo130_assertion SIO_000772 15968383 NP576115.RAChCy2fRh8bVqzfXuKuuZh3LD5AFkt4LRfXgFbGcICJo130_provenance.
- NP576115.RAChCy2fRh8bVqzfXuKuuZh3LD5AFkt4LRfXgFbGcICJo130_assertion wasDerivedFrom befree-20150227 NP576115.RAChCy2fRh8bVqzfXuKuuZh3LD5AFkt4LRfXgFbGcICJo130_provenance.
- NP576115.RAChCy2fRh8bVqzfXuKuuZh3LD5AFkt4LRfXgFbGcICJo130_assertion wasGeneratedBy ECO_0000203 NP576115.RAChCy2fRh8bVqzfXuKuuZh3LD5AFkt4LRfXgFbGcICJo130_provenance.